Shares of BioSig Technologies, Inc. (NASDAQ:BSGM – Get Free Report) traded up 10% on Friday . The stock traded as high as $0.32 and last traded at $0.32. 5,997 shares were traded during trading, a decline of 99% from the average session volume of 453,304 shares. The stock had previously closed at $0.29.
BioSig Technologies Trading Up 10.0 %
The firm has a 50-day moving average of $0.39 and a two-hundred day moving average of $0.81.
BioSig Technologies (NASDAQ:BSGM – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.30) earnings per share for the quarter. The company had revenue of $0.01 million during the quarter. As a group, equities analysts predict that BioSig Technologies, Inc. will post -1 EPS for the current year.
BioSig Technologies Company Profile
BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.
Further Reading
- Five stocks we like better than BioSig Technologies
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Stock Splits, Do They Really Impact Investors?
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Consumer Staples Stocks, Explained
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.